The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin

Surveillance of asymptomatic patients receiving prophylaxis with micafungin using sGM is unnecessary, because the results are either negative or false-positive. However, sGM remains useful in the diagnosis of breakthrough IA in symptomatic patients during prophylaxis.